- Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
- Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy
- Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
- Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC
- Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award
- Adlai Nortye Ltd. Announces Closing of Initial Public Offering
- Adlai Nortye Ltd. Announces Pricing of Initial Public Offering
More ▼
Key statistics
On Friday, Adlai Nortye Ltd (ANL:NMQ) closed at 3.49, 15.99% above the 52 week low of 3.01 set on Jul 09, 2024.
52-week range
Open | 3.50 |
---|---|
High | 3.50 |
Low | 3.40 |
Bid | 3.10 |
Offer | 3.75 |
Previous close | 3.45 |
Average volume | 4.57k |
---|---|
Shares outstanding | 12.30m |
Free float | 0.00 |
P/E (TTM) | -- |
Market cap | 128.83m USD |
EPS (TTM) | -7.26 USD |
Data delayed at least 15 minutes, as of Jul 26 2024 20:45 BST.
More ▼